New magnetic therapy for depression up to 80% effective
Stanford: American experts have achieved new successes in the treatment of depression with the help of magnetic force, in which about 80% of the patients not only got rid of the disease but did not reappear for several months.
The US Federal Bureau of Investigation (FDA) approved magnetic therapy for severe depression in October 2008, but it cures only 50 percent of patients and almost 33 percent of cases.
In this method, magnetic waves are focused on the patient’s scalp for a while by means of a special manual device, while this process is continued on a daily basis for six weeks.
Scientists at Stanford University have tried the same method on patients with severe depression in a slightly different way and have achieved a 78.6% success rate, although depression has not reappeared in them even after several months of recovery.
The only side effect of this treatment was temporary fatigue and headache.
The study recruited 29 volunteers between the ages of 22 and 80 who had been suffering from depression for an average of 9 years. Depression was so severe in all of them that they could not recover from the medication.
Of these, 15 volunteers underwent artificial (placebo) magnetic therapy for depression, while 14 underwent real magnetic therapy.
In each patient, the “best target” was selected to first focus the magnetic field with the help of MRI.
Since then, magnetic waves have been focused on this target 10 times a day. Each time, within ten minutes, 1800 waves of magnetic waves were applied to the area, after which the patient was allowed to rest for 50 minutes.
The positive effects of the new magnetic therapy began to show from day one.
After four weeks, in 11 of the 14 patients who received the original magnetic therapy, all the apparent symptoms of depression were almost gone, one patient had a significant recovery, and only one patient did not feel the effects of the treatment.
After several months of treatment, depression did not reappear in the recovering patients.